clazosentan 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
endothelin receptor antagonists 5518 180384-56-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • clazosentan
  • clazosentan sodium
  • pivlaz
  • Ro 61-1790
  • AXV-034343
  • VML 588
  • ACT-108475
Clazosentan is an endothelin receptor antagonist indicated for the prevention of cerebrovascular spasm after surgery for subarachnoid hemorrhage caused by cerebral aneurysm, and cerebral infarctions and cerebral ischemic symptoms accompanying the cerebrovascular spasm.
  • Molecular weight: 577.58
  • Formula: C25H23N9O6S
  • CLOGP: 2.11
  • LIPINSKI: 2
  • HAC: 15
  • HDO: 3
  • TPSA: 200.11
  • ALOGS: -4.13
  • ROTB: 10

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 -0.995 Moderate 0.67
caco2-efflux Caco-2 efflux ratio (BA/AB) 24.491 Moderate 0.67
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 0.274 10^-6 cm/s Moderate 0.67
dh-clint Dog hepatocyte intrinsic clearance 1.219 uL/min/10^6 cells Moderate 0.67
dppb Dog plasma protein binding (% unbound) 9.050 % Moderate 0.67
fcs-ppb Fetal calf serum protein binding (% unbound) 16.350 % Moderate 0.67
herg hERG pIC50 4.500 pIC50 Moderate 0.67
hh-clint Human hepatocyte intrinsic clearance 1.901 uL/min/10^6 cells Moderate 0.67
hlm-clint Human liver microsomal intrinsic clearance 4.188 uL/min/mg protein Moderate 0.67
hppb Human plasma protein binding (% unbound) 2.010 % Moderate 0.67
kinase-safety-class ACVR2B,AXL,BRAF,CAMK2B,CAMK2D,CDK5,CDK9,DYRK1B,EGFR,EIF2AK3,ERBB2,GRK2,ITK,MAP3K21,MAPK7,PDK1,PDK2,PDK4,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PRKDC,TEK 24
kinase-selectivity-class GRK2,MAPK7,SIK2 3
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 0.885 Moderate 0.67
mh-clint Mouse hepatocyte intrinsic clearance 11.614 Moderate 0.67
mppb Mouse plasma protein binding (% unbound) 9.760 Moderate 0.67
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 0.284 Moderate 0.67
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 7.390 % Moderate 0.67
rh-clint Rat hepatocyte intrinsic clearance 10.544 uL/min/10^6 cells Moderate 0.67
rh-fuinc Rat hepatocyte fraction unbound in incubation 73.810 % Moderate 0.67
rppb Rat plasma protein binding (% unbound) 2.850 % Moderate 0.67
solubility-dd Solubility at pH 7.4 in DMSO 981.748 uM Moderate 0.67

Approvals:

DateAgencyCompanyOrphan
Jan. 20, 2022 PMDA IDORSIA PHARMACEUTICALS JAPAN LTD

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C04AX33 CARDIOVASCULAR SYSTEM
PERIPHERAL VASODILATORS
PERIPHERAL VASODILATORS
Other peripheral vasodilators
CHEBI has role CHEBI:35554 cardiovascular drug

Related Drugs by ATC class:

C04AX Other peripheral vasodilators 16 drugs
azapetinebencyclanebuflomedilbutalaminecetiedilcinepazidecyclandelatefasudilifenprodilmoxisylytenaftidrofurylphenoxybenzamine show all 16 →

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Prevention of cerebrovascular spasm indication 73173006




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Endothelin-1 receptor GPCR ANTAGONIST Ki 9.89 CHEMBL SCIENTIFIC LITERATURE
Endothelin B receptor GPCR Ki 6.76 CHEMBL

External reference:

IDSource
CHEBI:748459 CHEBI
CHEMBL109648 ChEMBL_ID
C109641 MESH_SUPPLEMENTAL_RECORD_UI
12286 IUPHAR_LIGAND_ID
DB06677 DRUGBANK_ID
C1721268 UMLSCUI
CHEMBL5314590 ChEMBL_ID
D11664 KEGG_DRUG
8397 INN_ID
503271-02-1 SECONDARY_CAS_RN
6433095 PUBCHEM_CID
3DRR0X4728 UNII

Pharmaceutical products:

None